Filana Therapeutics Inc (FLNA) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB −0,97%	1 089,84	−10,73	−0,97%	—	1 100,57	1 098,94	1 103,80	1 084,24	—	—
SIXC Communications SIXC Communications	SIXC −0,20%	603,97	−1,18	−0,20%	—	605,15	605,15	606,69	602,76	—	—
SIXE Energy SIXE Energy	SIXE +2,01%	1 219,17	+23,98	+2,01%	—	1 195,19	1 204,71	1 221,69	1 204,71	—	—
SIXI Industrials SIXI Industrials	SIXI −1,36%	1 716,28	−23,63	−1,36%	—	1 739,91	1 734,50	1 734,50	1 710,67	—	—
SIXM Financials SIXM Financials	SIXM +0,57%	642,19	+3,63	+0,57%	—	638,56	640,21	645,32	639,66	—	—
SIXR Staples SIXR Staples	SIXR +1,51%	844,16	+12,59	+1,51%	—	831,57	840,48	844,04	834,54	—	—
SIXRE Real estate SIXRE Real estate	SIXRE +0,75%	214,97	+1,61	+0,75%	—	213,36	213,36	215,54	212,77	—	—
SIXT Technology SIXT Technology	SIXT −2,46%	3 154,69	−79,49	−2,46%	—	3 234,18	3 171,86	3 195,36	3 145,46	—	—
SIXU Utilities SIXU Utilities	SIXU +0,51%	940,41	+4,76	+0,51%	—	935,65	937,31	941,44	933,16	—	—
SIXV Health care SIXV Health care	SIXV +0,46%	1 455,97	+6,71	+0,46%	—	1 449,26	1 454,77	1 462,65	1 452,87	—	—
SIXY Discretionary SIXY Discretionary	SIXY −0,58%	2 368,64	−13,81	−0,58%	—	2 382,45	2 371,19	2 380,45	2 364,46	—	—

FLNA:NASDAQ

Filana Therapeutics Inc

1,57 USD

+0,57%

(+0,0089) 1 D

28. apr., 12:09:22 GMT-4 · USD

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for FLNA …

Åpne

1,57 USD

Høy

1,58 USD

Lav

1,55 USD

Markedsverdi

75,78 mill.

Snittvolum

407,12k

Volum

108,44k

52 u høy

2,27 USD

52 u lav

1,54 USD

EPS

−1,88 USD

Beta

−0,66

Utestående aksjer

48,31 mill.

Antall ansatte

Relaterte aksjer

MindWalk Holdings Corp

BridgeBio Oncology Therapeutics Inc

8,94 USD

+1,71%

Nyhetssaker

Fra kilder på nettet

Stock Titan

for 7 minutter siden

Nasdaq closes Li Bang delisting notice after 20 days above $1

WSJ

for 10 minutter siden

OpenAI Misses Key Revenue, User Targets in High-Stakes Sprint Toward IPO

Investor's Business Daily

for 24 minutter siden

Coca-Cola Leads Dow Jones After Earnings Top Views, But This Worries Executives

Yellow.com

for 1 time siden

Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings of Approximately $333 Million, Includes OpenAI, Beast Industries, More Than 11,000 ETH and Over 283 Million WLD Tokens

Profil

Filana Therapeutics, Inc. is an American pharmaceutical company based in Austin, Texas. The company was developing simufilam, an oral-tablet drug candidate for the treatment of Alzheimer's disease. Development of simufilam was discontinued in November 2024 after it failed to show clinical benefit in phase III clinical trials. In June 2024, the United States Department of Justice charged an advisor to company, Hoau-Yan Wang, with fraud over research results related to the experimental drug. Less than a month later, the president, chief executive officer and chairman of the board, Remi Barbier, resigned along with Lindsay Burns, his wife, who was the company's senior vice president and Wang's co-author. The U.S. Securities and Exchange Commission filed fraud charges in September 2024 against Barbier, Burns and Wang. The parties did not admit wrongdoing, but agreed to pay fines of the company $40 million, Barbier $175,000, Burns $85,000, and Wang $50,000. The DOJ dropped the fraud charges against Wang shortly before trial was scheduled to begin in October 2025 without giving a reason. Wikipedia

Om Filana Therapeutics Inc

Administrerende direktør-

Ansatte19

Grunnlagt1998

HovedkontorAustin, Texas, USA

Sektor-

Nettsted-

Alle verdier i USD	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	-	-	-	-
Varekostnad	13,67 mill.	5,12 mill.	3,96 mill.	3,85 mill.
Direkte driftskostnader	13,67 mill.	5,12 mill.	3,96 mill.	3,85 mill.
Utgifter til forskning og utvikling	-	-	-	-
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	7,92 mill.	8,98 mill.	7,90 mill.	5,70 mill.
Driftskostnader	7,92 mill.	8,98 mill.	7,90 mill.	5,70 mill.
Totale driftskostnader	21,59 mill.	14,09 mill.	11,86 mill.	9,55 mill.
Driftsinntekter	−21,59 mill.	−14,09 mill.	−11,86 mill.	−9,55 mill.
Andre ikke-operasjonelle inntekter	−82,00k	−46,00k	−114,00k	39,00k
EBT inkludert uvanlige elementer	−23,40 mill.	−44,22 mill.	−10,81 mill.	−12,54 mill.
EBT uten uvanlige elementer	−20,40 mill.	−12,92 mill.	−10,81 mill.	−8,54 mill.
Kostnad for inntektsskatt	-	-	-	-
Faktisk avgiftssats	-	-	-	-
Andre driftskostnader	-	-	-	-
Nettoinntekt	−23,40 mill.	−44,22 mill.	−10,81 mill.	−12,54 mill.
Netto fortjenestemargin	-	-	-	-
Resultat per aksje	-	-	-	-
Rente- og investeringsinntekter	1,26 mill.	1,21 mill.	1,17 mill.	974,00k
Rentekostnader	-	-	-	-
Netto rentekostnader	1,26 mill.	1,21 mill.	1,17 mill.	974,00k
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	−21,37 mill.	−13,87 mill.	−11,73 mill.	−9,18 mill.
Gevinst eller tap ved salg av eiendeler	-	-	-	-

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning